WOONSOCKET, R.I., September 1, 2017 - CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, president and chief executive officer, and Dave Denton, executive vice president and chief financial officer, will be speaking to investors at the Morgan Stanley Global Healthcare Conference on September 12, 2017, at approximately 8:00 a.m. ET.
An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website for all interested parties, and will be archived and available for a one-year period. To access the webcast or an archive of the event, visit http://investors.cvshealth.com.
About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.
Investor Contact:
Mike McGuire
Senior Vice President
Investor Relations
(401) 770-4050
Media Contact:
Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717